IFP Advisors Inc Has $5.07 Million Stake in Intuitive Surgical, Inc. $ISRG

IFP Advisors Inc raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,751 shares of the medical equipment provider’s stock after acquiring an additional 1,498 shares during the period. IFP Advisors Inc’s holdings in Intuitive Surgical were worth $5,071,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Brighton Jones LLC raised its stake in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the last quarter. Sivia Capital Partners LLC increased its holdings in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after purchasing an additional 34 shares during the period. Schnieders Capital Management LLC. raised its position in shares of Intuitive Surgical by 38.0% during the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after buying an additional 268 shares during the last quarter. Osterweis Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the second quarter valued at about $200,000. Finally, Main Street Financial Solutions LLC grew its position in Intuitive Surgical by 92.4% during the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after buying an additional 1,407 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Gary Guthart sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the transaction, the director directly owned 1,245,679 shares of the company’s stock, valued at approximately $498,271,600. The trade was a 0.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy Ladd sold 400 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the director owned 251 shares of the company’s stock, valued at approximately $95,129. This represents a 61.44% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 11,281 shares of company stock worth $4,485,432. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $353.24 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The firm’s 50 day simple moving average is $378.72 and its 200 day simple moving average is $425.22. The company has a market capitalization of $124.79 billion, a price-to-earnings ratio of 40.46, a P/E/G ratio of 2.64 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter in the previous year, the business posted $1.81 EPS. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. Equities research analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have commented on the company. Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Evercore set a $430.00 target price on Intuitive Surgical in a research note on Monday, July 6th. Robert W. Baird reduced their target price on Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Finally, The Goldman Sachs Group set a $558.00 price target on shares of Intuitive Surgical in a report on Wednesday, May 27th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $508.68.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: A large meta-analysis found that da Vinci robotic-assisted surgery was associated with statistically significant improvements across 13 common benign conditions, including shorter hospital stays and faster returns to work versus laparoscopic and open surgery. The findings support the clinical value of Intuitive’s platform and could help drive hospital adoption. New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery
• Positive Sentiment: BTIG reaffirmed its “buy” rating and assigned a $469 price target, implying substantial upside from recent trading levels. Other analyst commentary also remains broadly favorable, although investors may be discounting some recommendations because sell-side ratings tend to be optimistic. BTIG reaffirms buy rating on Intuitive Surgical
• Positive Sentiment: Articles note that ISRG is trading at its cheapest valuation in roughly a decade. Combined with recent revenue growth of about 18% and strong earnings execution, the lower valuation is attracting interest from value-oriented investors. ISRG stock trading at its cheapest in 10 years
• Neutral Sentiment: Intuitive presented at the Wells Fargo Healthcare Conference, keeping investor attention on procedure trends, guidance, competition, and the company’s long-term robotic-surgery opportunity. Intuitive Surgical Wells Fargo Healthcare Conference transcript
• Negative Sentiment: Recent selling pressure has been linked to slower U.S. procedure growth, rising costs, competitive threats, and potential effects from GLP-1 drugs. Investors are also questioning whether the company’s earnings multiple is justified while growth moderates. Why Intuitive Surgical fell more than the broader market
• Negative Sentiment: EVP Mark Brosius reported two sales totaling 69 shares. The transactions were made under a pre-arranged Rule 10b5-1 plan and are small relative to his remaining holdings, limiting their significance; however, broader insider activity has consisted predominantly of sales rather than purchases.

About Intuitive Surgical

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.